LUCKNOW, April 30 -- The Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI) has performed what may be India's first haploidentical stem cell transplant to treat Autoimmune Lymphoproliferative Syndrome (ALPS), a rare and potentially fatal genetic disorder. The patient, a nine-year-old boy from Banda (name withheld), had been battling severe symptoms since the age of four, including persistent ulcers, skin lesions and enlarged organs. He was diagnosed with ALPS at SGPGI by geneticist Dr Kaushik Mondal. The disorder causes the immune system to attack the body's own cells, leading to anaemia, infections and bleeding risks. While ALPS is usually managed with steroids, doctors opted for a stem cell transplant - the only potential cure in severe cases. In a complex procedure, the boy's father served as a half-matched donor. The transplant was carried out over six months, and the child has now recovered. The procedure was led by haematologist Dr Rajesh Kashyap with support from Dr Sayan Sinha Roy and team. SGPGI director Dr R K Dhiman said the case marks a major step in treating rare diseases. Dr Rajesh Kadhyap, said, "The success of the procedure has garnered international recognition, with the European Society for Blood and Marrow Transplantation selecting the case as the best oral abstract for its upcoming meeting." Dr. Sayan Sinha Roy and Dr Kadhyap are set to present the findings at this prestigious event....